Fineline Cube

Follow:
14446 Articles
Company

BeiGene’s Q1 2024 Revenue Jumps 68% YOY on Strength of Brukinsa and Tislelizumab Sales

CompanyDrug

Brii Biosciences’ BRII-835 Aims for Breakthrough Therapy Status in China for Chronic Hepatitis B

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Advances HRS-5965 with NMPA Clinical Trial Approval for Glomerular Diseases

Company

Organon’s Q1 2024 Revenues Rise 7% YOY, Women’s Health and Biosimilars Lead the Way

CompanyDrug

Innovent Biologics’ Mazdutide Shows Superiority in Type 2 Diabetes Phase III Trial

CompanyMedical Device

Blue Sail Medical’s New Catheter Receives NMPA Approval for Complex Coronary Lesion Treatment

CompanyDrug

Abbisko and Allist Pharmaceuticals Initiate Phase II Trial for NSCLC Drug Combination

CompanyR&D

Profluent’s Neural Network Model Designs High-Efficiency CRISPR Gene-Editing System

CompanyDrug

Boehringer Ingelheim’s Anti-Sema3A BI 764524 Shows Promise in Diabetic Macular Ischemia Trial

CompanyDrug

Pfizer Pauses Dosing in DMD Gene Therapy Trial Following Participant’s Sudden Death

CompanyDeals

Tonghua Dongbao Pharmaceuticals Inks Licensing Deal for Semaglutide in China

CompanyDrug

J&J’s Erleada Plus ADT Shows 0% Biochemical Recurrence Rate in High-Risk Prostate Cancer Trial